UK In-Vitro Diagnostic Market is predicted to reach USD 2.79 Billion by 2030

According to the study by Next Move Strategy Consulting, the UK In-Vitro Diagnostics Market size is predicted to reach USD 2.79 billion, at a CAGR of 2.1% by 2030.

Request a FREE Sample: https://www.nextmsc.com/uk-in-vitro-diagnostics-market/request-sample

The rapid increase in healthcare expenditure is significantly driving the growth of the in-vitro diagnostics market.

The prevalence of chronic disease such as cancer in the UK has been steadily increasing over the years, thereby propelling the demand for in-vitro diagnostics.

The promising players operating in the UK in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.